CervoMed Appoints Matthew Winton, Ph.D., as Chief Commercial and Business Officer

Go back to CervoMed Appoints Matthew Winton, Ph.D., as Chief Commercial and Business Officer
(NASDAQ: CRVO) Delayed: 2.62 +0.05 (1.95%)
Previous Close $2.57    52 Week High
Open $2.55    52 Week Low
Day High $2.64    P/E N/A 
Day Low $2.55    EPS
Volume 101,558